Gulf International Bank UK Ltd Cuts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Gulf International Bank UK Ltd reduced its stake in HCA Healthcare by 30.2%, owning 11,259 shares worth approximately $3.89 million after selling 4,866 shares in the first quarter.
• HCA Healthcare reported earnings of $6.84 per share, exceeding analyst estimates, and recorded a quarterly revenue of $18.61 billion, showing a 6.4% increase year-over-year.
• The company announced a quarterly dividend of $0.72 per share to be paid on September 30th, with a current yield of 0.7% and a payout ratio of 12.11%.

Gulf International Bank UK Ltd reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 30.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,259 shares of the company's stock after selling 4,866 shares during the quarter. Gulf International Bank UK Ltd's holdings in HCA Healthcare were worth $3,890,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Avantax Advisory Services Inc. increased its position in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after buying an additional 32 shares in the last quarter. Catalyst Financial Partners LLC increased its position in shares of HCA Healthcare by 4.3% in the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after buying an additional 36 shares in the last quarter. Moors & Cabot Inc. increased its position in shares of HCA Healthcare by 4.8% in the first quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock valued at $297,000 after buying an additional 39 shares in the last quarter. Perigon Wealth Management LLC increased its position in shares of HCA Healthcare by 2.3% in the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock valued at $621,000 after buying an additional 40 shares in the last quarter. Finally, Barden Capital Management Inc. increased its position in shares of HCA Healthcare by 1.4% in the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after buying an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.6%

Shares of HCA Healthcare stock traded up $2.18 during trading hours on Friday, hitting $395.83. The company's stock had a trading volume of 1,251,407 shares, compared to its average volume of 1,541,143. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a fifty day moving average of $370.53 and a 200-day moving average of $351.63. The stock has a market cap of $92.62 billion, a price-to-earnings ratio of 16.64, a P/E/G ratio of 1.24 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the company posted $5.50 EPS. The company's quarterly revenue was up 6.4% on a year-over-year basis. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. Royal Bank Of Canada lowered their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Barclays lowered their price target on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday, July 28th. Finally, Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Nine investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $398.58.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.